Thrombotic syndrome is a hemostatic disorder dominated by hypercoagulation. It is characterized by excessive thrombus formation, which leads to impaired blood flow and tissue damage.
Core ProcessImbalance among procoagulant, anticoagulant, and fibrinolytic factors.
Key ThreatRisk of thromboembolism, including life-threatening pulmonary embolism.
ConsequencesCirculatory hypoxia, dystrophy, and decreased organ function.
Main CausesAtherosclerosis, diabetes mellitus, hypertension, shock, and endotoxemia.
Pathophysiology of Hypercoagulation
The syndrome is based on an imbalance in the blood coagulation system. There are four key mechanisms:
Activation: excessive stimulation of factors responsible for coagulation and platelet aggregation.
Accumulation: an increase in the concentration of procoagulants and proaggregants in the bloodstream.
Deficiency: a decrease in the level or activity of natural anticoagulants and antiplatelet agents.
Suppression: inhibition of the fibrinolytic system, preventing timely thrombolysis.
Clinical Trigger Conditions
Thrombotic syndrome rarely occurs in isolation. It most commonly accompanies systemic diseases:
Cardiovascular: atherosclerosis and essential hypertension.
Posing a particular danger is the detachment of a venous thrombus. Entering the bloodstream, it becomes a thromboembolus, frequently leading to occlusion of the pulmonary arteries (pulmonary embolism).
Mnemonic
Remember the "4-4-4" formula: 4 mechanisms of hypercoagulation, 4 groups of causes (vascular, endocrine, shock-related, toxic), and 4 types of tissue damage (hypoxia, dystrophy, functional decline, hypotrophy).
Frequently asked questions
Which specific natural anticoagulants are depleted in the deficiency mechanism of thrombotic syndrome?
The deficiency mechanism in thrombotic syndrome involves a reduction in the level and/or activity of anticoagulants.
Natural anticoagulants include:
Antithrombin III.
Protein C.
Protein S.
Deficiency of antithrombin III, protein C, or protein S is a criterion for diagnosed thrombophilia. In nephrotic syndrome, urinary loss of natural anticoagulants—antithrombin III, protein C, and protein S—may occur, along with plasminogen.
Which specific procoagulants and proaggregants increase in concentration during the accumulation mechanism?
The accumulation mechanism in thrombotic syndrome involves increased blood concentrations of procoagulants and proaggregants.
Procoagulants include:
Fibrinogen.
Coagulation factors V, VII, VIII, and X.
Proaggregants include:
Thromboxane A₂.
ADP.
Prostaglandin F.
Prostaglandin E.
Catecholamines.
Antibodies to blood cells.
What factors cause the suppression of the fibrinolytic system in thrombotic syndrome?
Suppression of the fibrinolytic system in thrombotic syndrome is driven by increased activity of fibrinolysis inhibitors.
Factors inhibiting clot lysis include:
Tissue plasminogen activator inhibitors (PAI-1 and PAI-2), which neutralize plasminogen activators.
Antiplasmins, circulating blood substances that directly block the action of active plasmin.
This imbalance prevents the lysis of formed clots and promotes hypercoagulation.
What is the main difference between thrombotic and hemorrhagic syndromes?
Thrombotic syndrome is characterized by excessive clotting and the risk of vascular occlusion, whereas hemorrhagic syndrome presents with increased bleeding tendencies due to hemostatic factor deficiencies.
Why is the risk of thrombosis increased in diabetes mellitus?
Diabetes mellitus disrupts the balance of hemostatic factors, shifting it toward hypercoagulation and decreasing the activity of the fibrinolytic system.
What is circulatory hypoxia in thrombosis?
It is a condition where tissues suffer from oxygen deprivation because a thrombus physically obstructs normal blood flow within an organ.
Go deeper
Detailed analysis of the molecular mechanisms of procoagulant activation.
Comparative characteristics of venous and arterial thrombosis.
The role of the vascular endothelium in regulating anticoagulant activity.
Pathophysiological features of pulmonary embolism as a complication of thrombotic syndrome.